Recursion Pharmaceuticals, Inc.
RXRXHealthcareBiotechnology
市值
$1.70B
CEO
Najat Khan
员工数
800
行业
Biotechnology
上市日期
2021-04-16
收录人数
11
近期高管变动
04/30离任Christopher Gibson, Ph.D. Chair of the Board of Directors of Recursion Pharmaceuticals, Inc., member of the Research and Development Committee, Technology Committee, and the Corporate Social Responsibility Committee of the Board03/25离任David Mauro, M.D., Ph.D. 03/25上任Vicki Goodman, M.D. Chief Medical Officer03/25离任David Mauro, M.D., Ph.D. Chief Medical Officer11/05上任Najat Khan, Ph.D. Chief Executive Officer and President11/05上任Christopher Gibson, Ph.D. Chair of the Board11/05resignedChristopher Gibson, Ph.D. Chief Executive Officer and President03/18上任Elaine Sun Class III Director of the Board, Chair of the Audit Committee of the Board, Member of the Compensation Committee of the Board
B
Ben Taylor
Chief Financial Officer
高管
D
David Hallett
Chief Scientific Officer
高管
N
Najat Khan
CEO and President
董事高管
R
Robert Hershberg3家
董事
董事
C
Christopher Gibson2家
董事
董事
D
Dean Li2家
董事
董事
B
Blake Borgeson
董事
董事
E
Elaine Sun
董事
董事
F
Franziska Michor
董事
董事
N
Namandje Bumpus
董事
董事
Z
Zavain Dar
董事
董事